<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2464">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04319445</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00064587</org_study_id>
    <nct_id>NCT04319445</nct_id>
  </id_info>
  <brief_title>Mindfulness During COVID-19</brief_title>
  <official_title>Mindfulness During COVID-19 - Remote Mindfulness Sessions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to provide remote mindfulness session(s) to help during the
      COVID-19 pandemic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to provide remote mindfulness session(s) to help during the
      COVID-19 pandemic.The investigators are interested in targeting patients with migraine,
      providers, faculty and staff. The investigators are hopeful that this will positively impact
      overall well-being at this stressful time. The investigators are interested in assessing
      feasibility, accessibility, and overall interest of an online mindfulness intervention in
      these populations at this time.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Helpfulness of the session</measure>
    <time_frame>Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Total scale 1-5. Higher scores denotes better outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platform effectiveness</measure>
    <time_frame>Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Total scale 1-5. Higher scores denotes better outcomes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Anxiety Level</measure>
    <time_frame>Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Total scale 1-5. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stress Level</measure>
    <time_frame>Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Total scale 1-5. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Value of the session</measure>
    <time_frame>Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Total scale 1-5. Higher scores denotes better outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with the session</measure>
    <time_frame>Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Total scale 1-5. Higher scores denotes better outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants that showed interest in a future session</measure>
    <time_frame>Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants that would recommend this session to a family member</measure>
    <time_frame>Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants by session frequency preference</measure>
    <time_frame>Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Percentage of participants that would prefer to participate in daily, weekly or monthly similar sessions again if offered</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Concern level about the COVID 19 pandemic</measure>
    <time_frame>Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)</time_frame>
    <description>Total scale 1-5. Higher scores denotes worse outcomes.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Migraine Disorders</condition>
  <condition>Stress</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Migraine Patients/Providers/Faculty/Staff/Other</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness session(s)</intervention_name>
    <description>The sessions will be hosted online using an online platform (such as through webex, private YouTube page, Facebook live, etc).</description>
    <arm_group_label>Migraine Patients/Providers/Faculty/Staff/Other</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any person interested in participating in the mindfulness session will be eligible to
             complete the pre/post surveys and participate in the mindfulness session.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca E Wells, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca E Wells, MD, MPH</last_name>
    <phone>336-716-2357</phone>
    <email>WFBH_Mindfulness@wakehealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wake Forest Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Wells, MD</last_name>
      <email>WFBH_Mindfulness@wakehealth.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2020</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

